Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Mar 06 2023

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-mar-06-2023-8

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 06, 2023, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Fluorouracil Injection USP, 2.5 g/50 mL (50 mg/mL) Pharmacy Bulk Vial".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases